Startups Dave Loses Appeal Over Valuation similispharma@gmail.comJuly 29, 20260 StartupsBy Priya SharmaJuly 29, 20267 min read Key Takeaways Investors reassess Dave's valuation Competition intensifies in fintech Regulators scrutinize Australian…